世界の植込み型除細動器(ICD)市場:医療機器パイプライン分析2016

◆英語タイトル:Implantable Cardioverter Defibrillators (ICD) - Medical Devices Pipeline Assessment, 2016
◆商品コード:GDME0180EPD
◆発行会社(調査会社):GlobalData
◆発行日:2016年5月1日
◆ページ数:119
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥277,500見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥555,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥832,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、植込み型除細動器(ICD)のグローバル製品パイプライン動向について調査・分析し、以下の構成でお届けいたします。
・植込み型除細動器(ICD)の概要
・植込み型除細動器(ICD)の開発動向:開発段階別分析
・植込み型除細動器(ICD)の開発動向:セグメント別分析
・植込み型除細動器(ICD)の開発動向:領域別分析
・植込み型除細動器(ICD)の開発動向:規制Path別分析
・植込み型除細動器(ICD)の開発動向:承認日(推定)別分析
・企業別植込み型除細動器(ICD)の開発動向(パイプライン製品、進行中の治験)
・植込み型除細動器(ICD)の最近動向
【レポートの概要】

Implantable Cardioverter Defibrillators (ICD) – Medical Devices Pipeline Assessment, 2016

Summary

GlobalData’s Medical Devices sector report, “Implantable Cardioverter Defibrillators (ICD) – Medical Devices Pipeline Assessment, 2016″ provides an overview of Implantable Cardioverter Defibrillators (ICD) currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Cardioverter Defibrillators (ICD) pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Implantable Cardioverter Defibrillators (ICD) under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Implantable Cardioverter Defibrillators (ICD) and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Implantable Cardioverter Defibrillators (ICD) under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Implantable Cardioverter Defibrillators (ICD) Overview 8
3 Products under Development 9
3.1 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 9
3.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Segment 10
3.3 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Territory 11
3.4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Regulatory Path 12
3.5 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Estimated Approval Date 13
3.6 Implantable Cardioverter Defibrillators (ICD) – Ongoing Clinical Trials 14
4 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products under Development by Companies 15
4.1 Implantable Cardioverter Defibrillators (ICD) Companies – Pipeline Products by Stage of Development 15
4.2 Implantable Cardioverter Defibrillators (ICD) – Pipeline Products by Stage of Development 16
5 Implantable Cardioverter Defibrillators (ICD) Companies and Product Overview 17
5.1 AIS Inc. Company Overview 17
5.1.1 AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
5.2 Biotronik SE & Co. KG Company Overview 18
5.2.1 Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 18
5.3 Boston Scientific Corporation Company Overview 29
5.3.1 Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
5.4 CardiaLen, Inc. Company Overview 38
5.4.1 CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
5.5 InnerPulse, Inc. Company Overview 40
5.5.1 InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
5.6 Kenergy Inc. Company Overview 41
5.6.1 Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
5.7 Max Planck Institute for Dynamics and Self-Organization Company Overview 42
5.7.1 Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 42
5.8 Medtronic plc Company Overview 43
5.8.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43
5.9 Smartwave Medical Ltd Company Overview 47
5.9.1 Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
5.10 The Johns Hopkins University Company Overview 48
5.10.1 The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 48
5.11 University of Leicester Company Overview 52
5.11.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 52
6 Implantable Cardioverter Defibrillators (ICD)- Recent Developments 54
6.1 Apr 25, 2016: Philips’ First Quarter Results 2016 54
6.2 Apr 20, 2016: Boston Scientific Announces CE Mark For MRI Labeling Of Emblem S-ICD Systems 55
6.3 Apr 20, 2016: Boston Scientific Announces CE Mark For MRI Labeling Of Emblem S-ICD Systems 56
6.4 Apr 13, 2016: Nihon Kohden Evolves Brand, Website to Meet Needs of Changing Healthcare Environment 56
6.5 Apr 06, 2016: Medtronic Statement on U.S. Department of Treasury’s Recent Temporary and Proposed Regulations 57
6.6 Mar 17, 2016: Medtronic Proposes Proxy Access 57
6.7 Mar 10, 2016: Philips meets stringent U.S. government security requirements for pathology medical data 57
6.8 Mar 09, 2016: Management Changes at ZOLL Signal Stable Leadership and Steady Growth 58
6.9 Mar 01, 2016: Medtronic Reports Third Quarter Financial Results 59
6.10 Feb 22, 2016: Philips to introduce next-generation monitoring solution enabled by wearable biosensors 60
6.11 Feb 19, 2016: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2016 61
6.12 Feb 11, 2016: BIOTRONIK Announces CE Approval for new series of ICDs and CRT-Ds with MRI AutoDetect 61
6.13 Feb 03, 2016: Nihon Kohden America Receives Great Place to Work Certification 62
6.14 Jan 27, 2016: CONMED Announces Fourth Quarter and Fiscal Year 2015 Financial Results 62
6.15 Jan 11, 2016: Medtronic Updates Capital Allocation Plans and Fiscal 2016 EPS Guidance 63
6.16 Jan 11, 2016: HeartWare International Provides Corporate Updates And Announces Preliminary Revenue For Fourth Quarter 2015 64
6.17 Jan 05, 2016: Philips wants you to be the picture of health: showcases cloud-based technologies for every stage of life at CES 65
6.18 Dec 22, 2015: FDA Approves BIOTRONIK Iperia ICD Systems with Full-Body ProMRI Technology 66
6.19 Dec 21, 2015: Medtronic Receives First Health Canada License for MRI Conditional Implantable Cardioverter Defibrillator System 67
6.20 Dec 14, 2015: The Medtronic Bakken Invitation Award Honors 12 Patients from Around the World for Giving Back 68
6.21 Nov 23, 2015: Philips partnership with the RSNA Research & Education Foundation awards more than 110 grant recipients since 1991 69
6.22 Nov 20, 2015: Medtronic Statement on U.S. Department of Treasury’s Notice 2015-79 70
6.23 Nov 02, 2015: LivaNova Announces the Launch of the PLATINIUM ICD & CRT-D Family Providing the World’s Longest Projected Longevity 70
6.24 Oct 30, 2015: Nearly 500 Hospitals Pay United States More Than $250 Million to Resolve False Claims Act Allegations Related to Implantation of Cardiac Devices 71
6.25 Oct 29, 2015: HeartWare International Reports Third Quarter 2015 Results 72
6.26 Oct 21, 2015: CONMED Announces Third Quarter 2015 Financial Results 73
6.27 Oct 01, 2015: World’s First and Only ICD Offering 3 Tesla MRI Access Launched in Japan 74
6.28 Sep 28, 2015: Medtronic InFuse Lawsuit May Reach Supreme Court, Parker Waichman LLP Comments 75
6.29 Sep 15, 2015: Philips provides update on its performance trajectory and strategy to capture the opportunities in the HealthTech market at its Capital Markets Day 75
6.30 Sep 14, 2015: Medtronic First To Receive FDA Approval For MR-Conditional Implantable Cardioverter Defibrillator System 76
6.31 Sep 13, 2015: Physio-Control to Acquire HeartSine Technologies 77
6.32 Sep 10, 2015: Sorin and Cyberonics Announce Appointment of LivaNova’s Chief Financial Officer 77
6.33 Sep 08, 2015: No Further Legal Action By Italian State’s Attorney To Enjoin The Combination Of Sorin And Cyberonics 77
6.34 Sep 04, 2015: NORDIC ICD Trial Calls Defibrillation Testing during ICD Implantation into Question 78
6.35 Sep 03, 2015: Medtronic Reports First Quarter Financial Results 78
6.36 Sep 03, 2015: Philips introduces personal health programs at IFA in Berlin 81
6.37 Sep 02, 2015: Philips Healthcare Receives DOD Contract For Biomedical Equipment 82
6.38 Aug 31, 2015: Medtronic Study Detects Gene Associated with Sudden Cardiac Death 82
6.39 Aug 09, 2015: Philips Healthcare India Plans To Invest $60m To Double Production Capacity At Pune Facility 83
6.40 Aug 07, 2015: Financial Results for the First Quarter of Fiscal Year Ending March 31, 2016 84
6.41 Jul 31, 2015: Consolidated Financial Results for the 1st Quarter of the Fiscal Year Ending March 31, 2016 86
6.42 Jul 30, 2015: Sorin Group Announces Results for the Second Quarter of 2015 87
6.43 Jul 30, 2015: HeartWare Reports $73.6 Million In Second Quarter 2015 Revenue, Driven By Strong Global Unit Growth 90
6.44 Jul 28, 2015: BIOTRONIK Becomes First Manufacturer of Single- and Dual-Chamber Pacemakers and ICDs Approved for Use in 3 Tesla MRI Scans Worldwide 91
6.45 Jul 27, 2015: Sorin And Cyberonics Announce Intent To Vigorously Contest Claim By Italian State’s Attorney Seeking To Enjoin The Proposed Combination Of The Companies 92
6.46 Jul 27, 2015: Philips : Second Quarter Results 2015 92
6.47 Jul 21, 2015: Heart Failure Patients Now Have Expanded Therapy Options and Unique Pacing Features with New BIOTRONIK CRT-D Device 94
6.48 Jul 21, 2015: CONMED Announces Second Quarter 2015 Financial Results 94
6.49 Jul 14, 2015: Philips appoints Andy Ho as CEO for Greater China 95
6.50 Jul 01, 2015: BIOTRONIK Expands Japanese Portfolio with Itrevia 7 HF-T QP, Approved for 1.5 Tesla Scanning 96
6.51 Jun 25, 2015: Sorin And Cyberonics Unveil Name Of Combined Company: LivaNova 96
6.52 Jun 15, 2015: BIOTRONIK ProMRI ICD Clinical Study Results Published in HeartRhythm Journal 97
6.53 Jun 02, 2015: Medtronic Reports Fourth Quarter and Fiscal Year 2015 Financial Results 98
6.54 May 22, 2015: BIOTRONIK Brings Iforia 7 DR-T and VR-T DF4 Systems with ProMRI Technology to the Japanese Market 101
6.55 May 19, 2015: Medtronic Announces Preliminary Fourth Quarter and Fiscal Year 2015 Revenue Results 102
6.56 May 15, 2015: BIOTRONIK Presents ProMRI ICD Clinical Study Results at Heart Rhythm 2015 Scientific Sessions 105
6.57 May 14, 2015: Medtronic Evera MRI ICD Clinical Study Meets Safety and Efficacy Endpoints 105
6.58 May 13, 2015: St. Jude Medical Expands Portfolio of MRI-Compatible Devices to High Voltage in Europe 107
6.59 May 13, 2015: Zoll To Demonstrate Pediatric Cpr Electrodes, Advanced Resuscitation And Temperature Management Technologies At Nti 2015 108
6.60 May 12, 2015: Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger 109
6.61 May 11, 2015: Nihon Kohden Consolidated Financial Results For The Fiscal Year Ended March 31, 2015 110
6.62 May 08, 2015: JMS: Financial Results for the Fiscal Year Ended March 31, 2015 113
6.63 May 06, 2015: Medtronic to Unveil First-of-Its-Kind Clinical Data for Evera MRI SureScan implantable cardioverter-defibrillator (ICD) System at Heart Rhythm 2015 114
6.64 May 06, 2015: HeartWare Announces Private Placement of Notes Due 2021 for USD66 Million 115
6.65 May 05, 2015: Physio-Control Plans to Raise USD150 Million in Public Offering of Debt 115
7 Appendix 116
7.1 Methodology 116
7.2 About GlobalData 118
7.3 Contact Us 119
7.4 Disclaimer 119

1.1 List of Tables
Table 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 9
Table 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 10
Table 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 11
Table 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 12
Table 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 13
Table 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 14
Table 7: Implantable Cardioverter Defibrillators (ICD) Companies - Pipeline Products by Stage of Development 15
Table 8: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 16
Table 9: AIS Inc. Pipeline Products & Ongoing Clinical Trials Overview 17
Table 10: Guardian - Product Status 17
Table 11: Guardian - Product Description 17
Table 12: Biotronik SE & Co. KG Pipeline Products & Ongoing Clinical Trials Overview 18
Table 13: ProMRI Iforia 5 HF-T ICD - Product Status 19
Table 14: ProMRI Iforia 5 HF-T ICD - Product Description 19
Table 15: ProMRI Iforia 5 Series DR-T ICD - Product Status 20
Table 16: ProMRI Iforia 5 Series DR-T ICD - Product Description 20
Table 17: ProMRI Iforia 5 VR-T DX ICD - Product Status 21
Table 18: ProMRI Iforia 5 VR-T DX ICD - Product Description 21
Table 19: ProMRI Iforia 5 VR-T ICD - Product Status 22
Table 20: ProMRI Iforia 5 VR-T ICD - Product Description 22
Table 21: ProMRI Iforia 7 DR-T ICD - Product Status 23
Table 22: ProMRI Iforia 7 DR-T ICD - Product Description 23
Table 23: ProMRI Iforia 7 HF-T ICD - Product Status 24
Table 24: ProMRI Iforia 7 HF-T ICD - Product Description 24
Table 25: ProMRI Iforia 7 VR-T DX ICD - Product Status 25
Table 26: ProMRI Iforia 7 VR-T DX ICD - Product Description 25
Table 27: ProMRI Iforia 7 VR-T ICD - Product Status 26
Table 28: ProMRI Iforia 7 VR-T ICD - Product Description 26
Table 29: Biotronik SE & Co. KG - Ongoing Clinical Trials Overview 27
Table 30: ProMRI Iforia 5 Series DR-T ICD - ProMRI 3T ENHANCED Master Study 28
Table 31: Boston Scientific Corporation Pipeline Products & Ongoing Clinical Trials Overview 29
Table 32: EMBLEM MRI S-ICD System - Product Status 30
Table 33: EMBLEM MRI S-ICD System - Product Description 30
Table 34: EMBLEM S-ICD - Product Status 31
Table 35: EMBLEM S-ICD - Product Description 31
Table 36: MRI Compatible S-ICD - Product Status 32
Table 37: MRI Compatible S-ICD - Product Description 32
Table 38: S-ICD System 1.5 - Product Status 33
Table 39: S-ICD System 1.5 - Product Description 33
Table 40: S-ICD System 2.0 - Product Status 34
Table 41: S-ICD System 2.0 - Product Description 34
Table 42: VITALITY NXT Defibrillator - Product Status 35
Table 43: VITALITY NXT Defibrillator - Product Description 35
Table 44: Boston Scientific Corporation - Ongoing Clinical Trials Overview 36
Table 45: EMBLEM S-ICD - Understanding Outcomes with the EMBLEM S-ICD in Primary Prevention Patients with Low Ejection Fraction 37
Table 46: CardiaLen, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
Table 47: CardiaLen Device - Atrial Fibrillation - Product Status 38
Table 48: CardiaLen Device - Atrial Fibrillation - Product Description 38
Table 49: CardiaLen Device - Ventricular Arrhythmia - Product Status 39
Table 50: CardiaLen Device - Ventricular Arrhythmia - Product Description 39
Table 51: InnerPulse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 52: PICD - Product Status 40
Table 53: PICD - Product Description 40
Table 54: Kenergy Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 55: Unconditional MRI Compatible Implantable Defibrillator - Product Status 41
Table 56: Unconditional MRI Compatible Implantable Defibrillator - Product Description 41
Table 57: Max Planck Institute for Dynamics and Self-Organization Pipeline Products & Ongoing Clinical Trials Overview 42
Table 58: Implantable Defibrillator - Product Status 42
Table 59: Implantable Defibrillator - Product Description 42
Table 60: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 43
Table 61: Chronicle ICD - Product Status 44
Table 62: Chronicle ICD - Product Description 44
Table 63: Visia AF MRI SureScan Single-chamber ICD - Product Status 45
Table 64: Visia AF MRI SureScan Single-chamber ICD - Product Description 45
Table 65: Visia AF SureScan Single-chamber ICD - Product Status 46
Table 66: Visia AF SureScan Single-chamber ICD - Product Description 46
Table 67: Smartwave Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 47
Table 68: Fully Automatic Implantable Atrial Defibrillator - Product Status 47
Table 69: Fully Automatic Implantable Atrial Defibrillator - Product Description 47
Table 70: The Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 48
Table 71: Implantable Cardioverter Defibrillator System - Product Status 49
Table 72: Implantable Cardioverter Defibrillator System - Product Description 49
Table 73: The Johns Hopkins University - Ongoing Clinical Trials Overview 50
Table 74: Implantable Cardioverter Defibrillator System - UMBRELLA - Incidence of Arrhythmias in Spanish Population with a Medtronic ICD Implant 51
Table 75: University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 52
Table 76: Implantable Cardioverter Defibrillator - Product Status 53
Table 77: Implantable Cardioverter Defibrillator - Product Description 53
Table 78: Glossary 117

1.2 List of Figures
Figure 1: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Stage of Development 9
Figure 2: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Segment 10
Figure 3: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Territory 11
Figure 4: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Regulatory Path 12
Figure 5: Implantable Cardioverter Defibrillators (ICD) - Pipeline Products by Estimated Approval Date 13
Figure 6: Implantable Cardioverter Defibrillators (ICD) - Ongoing Clinical Trials 14

【掲載企業】

AIS Inc.
Biotronik SE & Co. KG
Boston Scientific Corporation
CardiaLen, Inc.
InnerPulse, Inc.
Kenergy Inc.
Max Planck Institute for Dynamics and Self-Organization
Medtronic plc
Smartwave Medical Ltd
The Johns Hopkins University
University of Leicester

【レポートのキーワード】

植込み型除細動器(ICD)

★調査レポート[世界の植込み型除細動器(ICD)市場:医療機器パイプライン分析2016]販売に関する免責事項
★調査レポート[世界の植込み型除細動器(ICD)市場:医療機器パイプライン分析2016]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆